Ms. Desiree Christine Swinney COTA

Recommended Articles

• How Lung Transplants for Cystic Fibrosis Patients Have Changed

  For those with cystic fibrosis (CF), lung infections are the greatest contributor to death. Lung inflammation, destruction, and chronic infection occurs due to the thick sticky mucus associated with CF.This over-proliferation of mucus occurs due to the mutated gene CFTR which is responsible for the...

• Antibiotics for Cystic Fibrosis

  Cystic fibrosis damages the lungs, digestive system, and other organs in the body. It affects the cells producing mucus, sweat, and digestive juices. It is caused due to defect in a gene. This gene changes a protein responsible for movement of salts in and out of cells. As a result, thick, sticky...

• Treating PCOS With Progestin Decreases the Chances of Pregnancy

  PCOS is a common medical problem faced by women. It is usually caused by an imbalance in reproductive hormones. This imbalance can lead to problems in the ovaries. In a normal state, the ovaries make the egg and release it every month as part of a healthy menstrual cycle, however, for those with...

• Study Proves that Happier Nurses Lead to Happier Patients

  The notion of happiness in the workplace has been a popular topic, especially in the healthcare field. However, recently, a direct relationship between the happiness of healthcare personnel and the quality of their service has been established, with an increase in the quality of the care provided...

• What Causes Hemorrhoids?

  Hemorrhoids are inflamed and swollen veins in the rectum, which is the last section of the digestive system. They can also occur at the opening of the anus. The veins in the lower rectum and anus tend to swell under pressure, which is basically what causes hemorrhoids. They cause severe pain in the...

• FDA Approves Baricitinib for Adults with Active Rheumatoid Arthritis

  On June 1st of 2018, the US Food and Drug Administration (FDA) approved Olumiant (Baricitinib) for the treatment of adults with moderate to severe rheumatoid arthritis (RA) who have had an inadequate response or intolerance to one or more TNF inhibitor therapies. “We are pleased to provide RA...